Bristol-Myers Squibb Company (BMY) : Bristol-Myers Squibb Company (BMY) had a healthy money flow of $44 million into the stock during the Fridays trading session. The value of bullish trades on upticks was $163.17 million, whereas, investors only sold shares worth $119.18 million on downticks. The stock closed the day with an up-down ratio of 1.37.The money flow in the block trades to the tune of $45.25 million shows that the bulls were dominant, the large players used the weakness in the stock to accumulate it for the long-term. $61.87 million worth of transactions were on upticks. A paltry $16.62 million worth of block trade transactions on downticks shows that the investors are reluctant to sell the stock down. The total up-down ratio of the upticks vs the downticks in block trades was 3.72. Bristol-Myers Squibb Company (BMY) stock slid $0.63 intraday and traded at 56.76, a change of -1.1% over previous days close. However, for the week, the company shares are -3.42% compared to previous weeks close.
The company Insiders own 0.24% of Bristol-Myers Squibb Company shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -16.68% . Institutional Investors own 73.15% of Bristol-Myers Squibb Company shares. During last six month period, the net percent change held by insiders has seen a change of -23.4%.
In a related news,The director of Bristol Myers Squibb Co, Andreotti Lamberto sold 23,200 shares at $59.14 on August 24, 2016. The Insider selling transaction had a total value worth of $1,372,048. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
Bristol-Myers Squibb Company (NYSE:BMY): stock was range-bound between the intraday low of $55.11 and the intraday high of $56.93 after having opened at $56.93 on Fridays session. The stock finally closed in the red at $56.93, a loss of -0.72%. The stock remained in the red for the whole trading day. The total traded volume was 34,001,001 shares. The stock failed to cross $56.93 in Fridays trading. The stocks closing price on Thursday was $56.76.
Bristol-Myers Squibb Company (BMY) : During the past 4 weeks, traders have been relatively bearish on Bristol-Myers Squibb Company (BMY), hence the stock is down -10.83% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -4.6% relative to the S&P 500. The 4-week change in the price of the stock is -10.95% and the stock has fallen -4.12% in the past 1 week.
Bristol-Myers Squibb Company (BMS) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products across the world. The Companys products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. The Company manufactures its products in the United States, Puerto Rico and in six foreign countries. The Company promotes the use of its products directly to healthcare professionals and providers, such as doctors, nurse practitioners, physician assistants, pharmacists, technologists, hospitals, Pharmacy Benefit Managers (PBMs) and Managed Care Organizations (MCOs). It also provides information about the use of its products to consumers in the United States through direct-to-consumer print, radio, television, and digital advertising and promotion. In addition, the Company holds rights to F001287, which is a preclinical, small-molecule IDO1-inhibitor.